Simultaneous ultra-sensitive analysis of tamsulosin hydrochloride and tolterodine tartrate binary mixture in their dosage form via high-performance thin-layer chromatography with fluorimetric detection

被引:0
作者
M. Rizk
Zainab M. Mahmoud
Marwa M. Azab
机构
[1] Helwan University,Analytical Chemistry Department, Faculty of Pharmacy
来源
JPC – Journal of Planar Chromatography – Modern TLC | 2022年 / 35卷
关键词
Benign prostatic hyperplasia; Tamsulosin hydrochloride; Tolterodine tartrate; High-performance thin-layer chromatography; Fluorescence;
D O I
暂无
中图分类号
学科分类号
摘要
A simple, sensitive, selective, and stability-indicating high-performance thin-layer chromatography method with fluorescence detection was developed for the analysis of a mixture of tamsulosin hydrochloride and tolterodine tartrate, used in the management of benign prostatic hyperplasia in their laboratory-prepared binary mixture and dosage form. The separation was employed on thin-layer chromatography silica gel 60 aluminum sheets. As developing system, ethyl acetate–n-hexane–diethylamine (9:3:1, V/V) was used. Tamsulosin and tolterodine had retention factors (RF) of 0.40 ± 0.03 and 0.85 ± 0.03, respectively. A 225 nm excitation wavelength was used for the fluorescence detection. Linearity was in the range of 10.0–200.0 and 100.0–900.0 ng/band for tamsulosin and tolterodine, respectively. The method was validated successfully according to the International Council for Harmonisation guidelines. Our suggested method for determining tamsulosin and tolterodine in their dosage forms and in the presence of their degradation products could be conveniently applied in quality-control laboratories.
引用
收藏
页码:509 / 517
页数:8
相关论文
共 101 条
  • [1] Foo KT(2019)What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)? World J Urol 37 1293-1296
  • [2] Cao Y(2016)A randomized, open-label, comparative study of efficacy and safety of tolterodine combined with tamsulosin or doxazosin in patients with benign prostatic hyperplasia Med Sci Monit 22 1895-338
  • [3] Wang Y(2013)Comparative dissolution studies of an extended release Formulation of Tolterodine Tartrate and Tamsulosin HCl BioMedRx 1 333-S1867
  • [4] Guo L(2013)Various analytical methodologies for determination of selective α1A receptor blocker tamsulosin hydrochloride and its combinations in different matrices World J Anal Chem 1 55006092-779
  • [5] Yang X(2017)Simultaneous estimation of dutasteride and tamsulosin hydrochloride in tablet dosage form by vierordt’s method Arab J Chem 10 S1862-862
  • [6] Chen T(2018)Enhanced spectrofluorimetric determination of two novel combination therapies for the treatment of benign prostatic hyperplasia containing tamsulosin hydrochloride Luminescence 33 771-29
  • [7] Niu H(2016)Stability indicating HPLC method for quantification of solifenacin succinate & tamsulosin hydrochloride along with its impurities in tablet dosage form Am J Anal Chem 7 840-37
  • [8] Mhamunkar S(2017)Superparamagnetic graphene oxide-based dispersive-solid phase extraction for preconcentration and determination of tamsulosin hydrochloride in human plasma by high-performance liquid chromatography–ultraviolet detection J Chromatogr A 1499 21-295
  • [9] Mhamunkar SM(2019)Simultaneous HPLC determination of alfuzosin, tamsulosin and vardenafil in human plasma and pharmaceutical formulations using time programmed fluorescence detection Ann Pharm Fr 77 28-101
  • [10] Srinivasan G(2021)Eco-friendly RP-HPLC and HPTLC methods for simultaneous determination of tamsulosin hydrochloride and deflazacort in the presence of 21-hydroxy deflazacort and testing the in-vitro dissolution of the combined dosage form via RP-HPLC method Chromatographia 84 285-101